Back to search
Anti-VEGF Treatment
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anti-VEGF Treatment trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Anti-VEGF Treatment trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study collects information about complications and clinical response in cancer patients treated with anti-VEGF-related therapies. This study aims to observ…
Multicentre, open-label, single arm phase II study for patients with PM previously treated by immunotherapy and standard chemotherapy. 38 patients will be given…
This is a multi-site, open-label, dose-finding study, consisting of Parts 1, 2a, and 2b to investigate the combination of BNT326 with pumitamig (also known as B…
The purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biolog…
The goal of this observational study is to quantify iris blood flow via non-invasive eye scanning for evaluating ocular lesions in adults aged 18 years and olde…
This study will evaluate the safety, efficacy, optimal dose, and pharmacokinetics (PK) of BNT326 as monotherapy (Part 1) and as combination treatment with immun…
The goal of this clinical research study is to learn if Avastin (bevacizumab) can help to control ovarian, fallopian, or primary peritoneal cancer that has been…
This research study is studying a combination of two drugs that change the immune system and tumor as a possible treatment for metastatic or unresectable stage…